世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

詳細検索

詳細検索

Global DNA Read, Write, and Edit Market

Global DNA Read, Write, and Edit Market


Report Scope The scope of the global DNA read, write, and edit market study encompasses market size analysis, as well as a detailed examination of the competitive environment, market dynamics, ong... もっと見る

 

 

出版社
BCC Research
BCCリサーチ
出版年月
2026年3月10日
電子版価格
US$4,650
シングルユーザライセンス(印刷不可)
ライセンス・価格情報/注文方法はこちら
納期
2-3営業日以内
ページ数
142
言語
英語

英語原文をAI翻訳して掲載しています。


 

ページTOPに戻る



図表リスト

List of Tables
Summary Table : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 1 : DNA Read, Write, and Edit Technology Overview
Table 2 : Asia-Pacific: Regulatory Landscape
Table 3 : RoW: Regulatory Landscape
Table 4 : Global DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 5 : Global DNA Read Market, by Region, Through 2030
Table 6 : Global DNA Read Market, by Product and Service Type, Through 2030
Table 7 : Global DNA Read Consumables Market, by Region, Through 2030
Table 8 : Sequencing Consumables Offered by Major Companies
Table 9 : Global DNA Read Instruments Market, by Region, Through 2030
Table 10 : Sequencing Instruments Offered by Major Companies
Table 11 : Global DNA Read Software and Services Market, by Region, Through 2030
Table 12 : Global DNA Write Market, by Region, Through 2030
Table 13 : Global DNA Write Market, by Type, Through 2030
Table 14 : Global Gene Synthesis Market, by Region, Through 2030
Table 15 : Global Oligonucleotide Synthesis Market, by Region, Through 2030
Table 16 : Global DNA Edit Market, by Region, Through 2030
Table 17 : Global DNA Edit Market, by Editing Technology, Through 2030
Table 18 : Global CRISPR-based DNA Edit Market, by Region, Through 2030
Table 19 : Global TALEN-Based DNA Edit Market, by Region, Through 2030
Table 20 : Global ZFN-Based DNA Edit Market, by Region, Through 2030
Table 21 : Global Meganucleases-Based DNA Edit Market, by Region, Through 2030
Table 22 : Global DNA Read, Write, and Edit Market, by Application, Through 2030
Table 23 : Annual Occurrence Rate of Common Birth Defects in the U.S.
Table 24 : Global DNA Read, Write, and Edit Market for Clinical Applications, by Region, Through 2030
Table 25 : Global DNA Read, Write, and Edit Market for Research Applications, by Region, Through 2030
Table 26 : Global DNA Read, Write, and Edit Market for Applied Applications, by Region, Through 2030
Table 27 : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 28 : North American DNA Read, Write, and Edit Market, by Country, Through 2030
Table 29 : North American DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 30 : North American DNA Read Market, by Product and Service Type, Through 2030
Table 31 : North American DNA Write Market, by Type, Through 2030
Table 32 : North American DNA Edit Market, by Editing Technology, Through 2030
Table 33 : North American DNA Read, Write, and Edit Market, by Application, Through 2030
Table 34 : U.S. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 35 : U.S. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 36 : Canadian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 37 : Canadian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 38 : Mexican DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 39 : Mexican DNA Read, Write, and Edit Market, by Application, Through 2030
Table 40 : European DNA Read, Write, and Edit Market, by Country, Through 2030
Table 41 : European DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 42 : European DNA Read Market, by Product and Service Type, Through 2030
Table 43 : European DNA Write Market, by Type, Through 2030
Table 44 : European DNA Edit Market, by Editing Technology, Through 2030
Table 45 : European DNA Read, Write, and Edit Market, by Application, Through 2030
Table 46 : German DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 47 : German DNA Read, Write, and Edit Market, by Application, Through 2030
Table 48 : U.K. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 49 : U.K. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 50 : French DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 51 : French DNA Read, Write, and Edit Market, by Application, Through 2030
Table 52 : Italian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 53 : Italian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 54 : Spanish DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 55 : Spanish DNA Read, Write, and Edit Market, by Application, Through 2030
Table 56 : Rest of Europe DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 57 : Rest of Europe DNA Read, Write, and Edit Market, by Application, Through 2030
Table 58 : Asia-Pacific DNA Read, Write, and Edit Market, by Country, Through 2030
Table 59 : Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 60 : Asia-Pacific DNA Read Market, by Product and Service Type, Through 2030
Table 61 : Asia-Pacific DNA Write Market, by Type, Through 2030
Table 62 : Asia-Pacific DNA Edit Market, by Editing Technology, Through 2030
Table 63 : Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 64 : Chinese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 65 : Chinese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 66 : Japanese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 67 : Japanese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 68 : South Korean DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 69 : South Korean DNA Read, Write, and Edit Market, by Application, Through 2030
Table 70 : Indian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 71 : Indian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 72 : Australian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 73 : Australian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 74 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 75 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 76 : RoW DNA Read, Write, and Edit Market, by Sub-region, Through 2030
Table 77 : RoW DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 78 : RoW DNA Read Market, by Product and Service Type, Through 2030
Table 79 : RoW DNA Write Market, by Type, Through 2030
Table 80 : RoW DNA Edit Market, by Editing Technology, Through 2030
Table 81 : RoW DNA Read, Write, and Edit Market, by Application, Through 2030
Table 82 : Competitive Ranking of the DNA Read Market
Table 83 : Recent Developments in the DNA Read, Write, and Edit Market, 2023–2025
Table 84 : Key Investment Deals in the DNA Read, Write, and Edit Industry, 2024 and 2025
Table 85 : Environmental Performance Initiatives in the DNA Read, Write, and Edit Market
Table 86 : Social Performance Initiatives in the DNA Read, Write, and Edit Market
Table 87 : Governance Performance Initiatives in the DNA Read, Write, and Edit Market
Table 88 : ESG Risk Rankings for DNA Read, Write, and Edit Companies, 2025
Table 89 : Report Information Sources
Table 90 : Abbreviations Used in the Global DNA Read, Write, and Edit Market
Table 91 : Agilent Technologies Inc.: Company Snapshot
Table 92 : Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
Table 93 : Agilent Technologies Inc.: Product Portfolio
Table 94 : Agilent Technologies Inc.: News/Key Developments, 2024 and 2025
Table 95 : Beam Therapeutics: Company Snapshot
Table 96 : Beam Therapeutics: Financial Performance, FY 2023 and 2024
Table 97 : Beam Therapeutics: Product Portfolio
Table 98 : Beam Therapeutics: News/Key Developments, 2023
Table 99 : Charles River Laboratories: Company Snapshot
Table 100 : Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 101 : Charles River Laboratories: Product Portfolio
Table 102 : Eurofins Genomics: Company Snapshot
Table 103 : Eurofins Genomics: Product Portfolio
Table 104 : Eurofins Genomics: News/Key Developments, 2024
Table 105 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 106 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 107 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 108 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023−2025
Table 109 : GenScript: Company Snapshot
Table 110 : GenScript: Financial Performance, FY 2023 and 2024
Table 111 : GenScript: Product Portfolio
Table 112 : GenScript: News/Key Developments, 2024 and 2025
Table 113 : Illumina Inc.: Company Snapshot
Table 114 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 115 : Illumina Inc.: Product Portfolio
Table 116 : Illumina Inc.: News/Key Developments, 2025
Table 117 : Integrated DNA Technologies Inc.: Company Snapshot
Table 118 : Integrated DNA Technologies Inc.: Product Portfolio
Table 119 : Integrated DNA Technologies Inc.: News/Key Developments, 2023
Table 120 : Merck KGaA: Company Snapshot
Table 121 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 122 : Merck KGaA: Product Portfolio
Table 123 : Merck KGaA: News/Key Developments, 2025
Table 124 : Oxford Nanopore Technologies plc.: Company Snapshot
Table 125 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
Table 126 : Oxford Nanopore Technologies plc.: Product Portfolio
Table 127 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024 and 2025
Table 128 : PacBio: Company Snapshot
Table 129 : PacBio: Financial Performance, FY 2023 and 2024
Table 130 : PacBio: Product Portfolio
Table 131 : PacBio: News/Key Developments, 2025
Table 132 : QIAGEN: Company Snapshot
Table 133 : QIAGEN: Financial Performance, FY 2023 and 2024
Table 134 : QIAGEN: Product Portfolio
Table 135 : QIAGEN: News/Key Developments, 2025
Table 136 : Revvity: Company Snapshot
Table 137 : Revvity: Financial Performance, FY 2023 and 2024
Table 138 : Revvity: Product Portfolio
Table 139 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 140 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 141 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 142 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
Table 143 : Vertex Pharmaceuticals Inc.: Company Snapshot
Table 144 : Vertex Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 145 : Vertex Pharmaceuticals Inc.: Product Portfolio
Table 146 : Vertex Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 147 : List of a Few Emerging Startups

 

ページTOPに戻る


 

Summary

Report Scope
The scope of the global DNA read, write, and edit market study encompasses market size analysis, as well as a detailed examination of the competitive environment, market dynamics, ongoing research, and driving trends driving market growth. The market has been segmented based on technology, application, and region.
The report provides an overview of the global DNA read, write, and edit market, analyzing market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.
The report covers the total market for DNA read, write, and edit, which includes DNA sequencing, DNA writing, and gene editing. Applications for these products in clinical, research, and other applied areas are also included in the report. The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, the Asia-Pacific, and the Rest of the World, with a focus on major countries in these regions.
The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and emerging technologies related to the market. It also covers a section on the regulatory landscape of the industry.
The report concludes with an analysis of the competitive landscape and industry structure. It also has a dedicated section of company profiles that covers details of leading companies in the market.
Report Includes
- 89 data tables and 59 additional tables
- An overview of the global market for DNA read, write and edit technologies
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to DNA read, write and edit technologies, accompanied by a market share analysis by technology, application, and region
- Analysis of current and future demand in the global DNA read, write and edit technologies, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges, and opportunities affecting market growth
- Information on sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
- A look at the evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, and ESG trends of the market
- Market share analysis of the key market participants, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of major players within the industry, including Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Oxford Nanopore Technologies plc., and BGI

ページTOPに戻る


Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Sequencing Technologies
Sanger Sequencing
Third-Generation Sequencing
Gene Synthesis Processes
Solid Phase Chemical Synthesis
Genome Editing Technologies
Meganucleases
Zinc Finger Nucleases (ZFNs)
Transcription Activator-like Effector Nucleases (TALENs)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated Protein 9 (Cas9)
Porter’s Five Forces Analysis in the DNA Read, Write, and Edit Market
Macroeconomic Factor Analysis
U.S. Tariffs
Geopolitical Factors
Increasing Healthcare Expenditures
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Need for Early Detection of Chronic Diseases
Increasing Prevalence of Infectious Diseases
Growing Private Funding for Genome Editing
Market Restraints
Complex and Evolving Regulatory Landscape
High Costs of Sequencing Instruments
Off-Target Impacts of CRISPR Technology
Market Opportunities
Expanding Clinical Applications of Genome Editing
Applications in Plant and Livestock Breeding
Development of Next-Generation CAR-T Therapies
Chapter 4 Regulatory Landscape
Regulatory Paths for Genome Editing
North America
Europe (EU)
Asia-Pacific
Regulatory Landscape Across the Rest of the World
Chapter 5 Emerging Technologies
Key Takeaways
Emerging Technologies
Advances in Sequencing Technologies
In Vivo Delivery of CRISPR
CRISPR-Based Diagnostics
Artificial Intelligence (AI) in DNA Data Analysis
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Key Takeaways
DNA Read (Sequencing)
DNA Write (Synthesis)
DNA Edit (Genome Editing)
Market Analysis by Application
Key Takeaways
Clinical Applications
Research
Applied
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Industry Structure
Competitive Analysis of the DNA Read Market
Strategic Analysis
Funding Outlook
Chapter 8 Sustainability in the DNA Read, Write, and Edit Market: An ESG Perspective
Introduction to ESG
ESG Practices in the DNA Read, Write, and Edit Industry
Environmental Performance
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Acronyms
Company Profiles
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CHARLES RIVER LABORATORIES
EUROFINS GENOMICS
F. HOFFMANN-LA ROCHE LTD.
GENSCRIPT
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MERCK KGAA
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
VERTEX PHARMACEUTICALS INC.
Emerging Startups/ Market Disruptors

ページTOPに戻る



List of Tables/Graphs

List of Tables
Summary Table : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 1 : DNA Read, Write, and Edit Technology Overview
Table 2 : Asia-Pacific: Regulatory Landscape
Table 3 : RoW: Regulatory Landscape
Table 4 : Global DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 5 : Global DNA Read Market, by Region, Through 2030
Table 6 : Global DNA Read Market, by Product and Service Type, Through 2030
Table 7 : Global DNA Read Consumables Market, by Region, Through 2030
Table 8 : Sequencing Consumables Offered by Major Companies
Table 9 : Global DNA Read Instruments Market, by Region, Through 2030
Table 10 : Sequencing Instruments Offered by Major Companies
Table 11 : Global DNA Read Software and Services Market, by Region, Through 2030
Table 12 : Global DNA Write Market, by Region, Through 2030
Table 13 : Global DNA Write Market, by Type, Through 2030
Table 14 : Global Gene Synthesis Market, by Region, Through 2030
Table 15 : Global Oligonucleotide Synthesis Market, by Region, Through 2030
Table 16 : Global DNA Edit Market, by Region, Through 2030
Table 17 : Global DNA Edit Market, by Editing Technology, Through 2030
Table 18 : Global CRISPR-based DNA Edit Market, by Region, Through 2030
Table 19 : Global TALEN-Based DNA Edit Market, by Region, Through 2030
Table 20 : Global ZFN-Based DNA Edit Market, by Region, Through 2030
Table 21 : Global Meganucleases-Based DNA Edit Market, by Region, Through 2030
Table 22 : Global DNA Read, Write, and Edit Market, by Application, Through 2030
Table 23 : Annual Occurrence Rate of Common Birth Defects in the U.S.
Table 24 : Global DNA Read, Write, and Edit Market for Clinical Applications, by Region, Through 2030
Table 25 : Global DNA Read, Write, and Edit Market for Research Applications, by Region, Through 2030
Table 26 : Global DNA Read, Write, and Edit Market for Applied Applications, by Region, Through 2030
Table 27 : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 28 : North American DNA Read, Write, and Edit Market, by Country, Through 2030
Table 29 : North American DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 30 : North American DNA Read Market, by Product and Service Type, Through 2030
Table 31 : North American DNA Write Market, by Type, Through 2030
Table 32 : North American DNA Edit Market, by Editing Technology, Through 2030
Table 33 : North American DNA Read, Write, and Edit Market, by Application, Through 2030
Table 34 : U.S. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 35 : U.S. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 36 : Canadian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 37 : Canadian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 38 : Mexican DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 39 : Mexican DNA Read, Write, and Edit Market, by Application, Through 2030
Table 40 : European DNA Read, Write, and Edit Market, by Country, Through 2030
Table 41 : European DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 42 : European DNA Read Market, by Product and Service Type, Through 2030
Table 43 : European DNA Write Market, by Type, Through 2030
Table 44 : European DNA Edit Market, by Editing Technology, Through 2030
Table 45 : European DNA Read, Write, and Edit Market, by Application, Through 2030
Table 46 : German DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 47 : German DNA Read, Write, and Edit Market, by Application, Through 2030
Table 48 : U.K. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 49 : U.K. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 50 : French DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 51 : French DNA Read, Write, and Edit Market, by Application, Through 2030
Table 52 : Italian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 53 : Italian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 54 : Spanish DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 55 : Spanish DNA Read, Write, and Edit Market, by Application, Through 2030
Table 56 : Rest of Europe DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 57 : Rest of Europe DNA Read, Write, and Edit Market, by Application, Through 2030
Table 58 : Asia-Pacific DNA Read, Write, and Edit Market, by Country, Through 2030
Table 59 : Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 60 : Asia-Pacific DNA Read Market, by Product and Service Type, Through 2030
Table 61 : Asia-Pacific DNA Write Market, by Type, Through 2030
Table 62 : Asia-Pacific DNA Edit Market, by Editing Technology, Through 2030
Table 63 : Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 64 : Chinese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 65 : Chinese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 66 : Japanese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 67 : Japanese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 68 : South Korean DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 69 : South Korean DNA Read, Write, and Edit Market, by Application, Through 2030
Table 70 : Indian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 71 : Indian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 72 : Australian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 73 : Australian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 74 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 75 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 76 : RoW DNA Read, Write, and Edit Market, by Sub-region, Through 2030
Table 77 : RoW DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 78 : RoW DNA Read Market, by Product and Service Type, Through 2030
Table 79 : RoW DNA Write Market, by Type, Through 2030
Table 80 : RoW DNA Edit Market, by Editing Technology, Through 2030
Table 81 : RoW DNA Read, Write, and Edit Market, by Application, Through 2030
Table 82 : Competitive Ranking of the DNA Read Market
Table 83 : Recent Developments in the DNA Read, Write, and Edit Market, 2023–2025
Table 84 : Key Investment Deals in the DNA Read, Write, and Edit Industry, 2024 and 2025
Table 85 : Environmental Performance Initiatives in the DNA Read, Write, and Edit Market
Table 86 : Social Performance Initiatives in the DNA Read, Write, and Edit Market
Table 87 : Governance Performance Initiatives in the DNA Read, Write, and Edit Market
Table 88 : ESG Risk Rankings for DNA Read, Write, and Edit Companies, 2025
Table 89 : Report Information Sources
Table 90 : Abbreviations Used in the Global DNA Read, Write, and Edit Market
Table 91 : Agilent Technologies Inc.: Company Snapshot
Table 92 : Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
Table 93 : Agilent Technologies Inc.: Product Portfolio
Table 94 : Agilent Technologies Inc.: News/Key Developments, 2024 and 2025
Table 95 : Beam Therapeutics: Company Snapshot
Table 96 : Beam Therapeutics: Financial Performance, FY 2023 and 2024
Table 97 : Beam Therapeutics: Product Portfolio
Table 98 : Beam Therapeutics: News/Key Developments, 2023
Table 99 : Charles River Laboratories: Company Snapshot
Table 100 : Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 101 : Charles River Laboratories: Product Portfolio
Table 102 : Eurofins Genomics: Company Snapshot
Table 103 : Eurofins Genomics: Product Portfolio
Table 104 : Eurofins Genomics: News/Key Developments, 2024
Table 105 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 106 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 107 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 108 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023−2025
Table 109 : GenScript: Company Snapshot
Table 110 : GenScript: Financial Performance, FY 2023 and 2024
Table 111 : GenScript: Product Portfolio
Table 112 : GenScript: News/Key Developments, 2024 and 2025
Table 113 : Illumina Inc.: Company Snapshot
Table 114 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 115 : Illumina Inc.: Product Portfolio
Table 116 : Illumina Inc.: News/Key Developments, 2025
Table 117 : Integrated DNA Technologies Inc.: Company Snapshot
Table 118 : Integrated DNA Technologies Inc.: Product Portfolio
Table 119 : Integrated DNA Technologies Inc.: News/Key Developments, 2023
Table 120 : Merck KGaA: Company Snapshot
Table 121 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 122 : Merck KGaA: Product Portfolio
Table 123 : Merck KGaA: News/Key Developments, 2025
Table 124 : Oxford Nanopore Technologies plc.: Company Snapshot
Table 125 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
Table 126 : Oxford Nanopore Technologies plc.: Product Portfolio
Table 127 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024 and 2025
Table 128 : PacBio: Company Snapshot
Table 129 : PacBio: Financial Performance, FY 2023 and 2024
Table 130 : PacBio: Product Portfolio
Table 131 : PacBio: News/Key Developments, 2025
Table 132 : QIAGEN: Company Snapshot
Table 133 : QIAGEN: Financial Performance, FY 2023 and 2024
Table 134 : QIAGEN: Product Portfolio
Table 135 : QIAGEN: News/Key Developments, 2025
Table 136 : Revvity: Company Snapshot
Table 137 : Revvity: Financial Performance, FY 2023 and 2024
Table 138 : Revvity: Product Portfolio
Table 139 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 140 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 141 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 142 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
Table 143 : Vertex Pharmaceuticals Inc.: Company Snapshot
Table 144 : Vertex Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 145 : Vertex Pharmaceuticals Inc.: Product Portfolio
Table 146 : Vertex Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 147 : List of a Few Emerging Startups

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


BCC Research社はどのような調査会社ですか?


BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。   設立初期は先端材料とプラ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/03/17 10:26

160.37 円

184.58 円

216.03 円

ページTOPに戻る